返回 Agenda
Session 3: Global Perspectives on Disclosure
Session Chair(s)
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Merete-J Consulting, Denmark
The focus of this session is to consider the ever-changing clinical trials disclosure and transparency requirements in a global perspective. How trial sponsors can stay aware of the requirements from all countries and regions where they conduct clinical research and market products. Strategic considerations and questions to consider for trial sponsors in order to meet global clinical trials transparency requirements will be shared.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize how and where to find sources for global clinical trials transparency requirements
- Appraise and evaluate the transparency requirements in global perspective
- Integrate experience from different sponsor organizations approach to strategic considerations for clinical research
Speaker(s)
Thomas Wicks, MBA
Head of Transparency Operations, Citeline, United States
What in the World is Going on? Navigating Evolving Disclosure Mandates
Lora Killian, MBA
Clinical Trial Transparency and Disclosure Lead, Pfizer, United States
Assessment of the Impact of Disclosure Platforms, Study with EFPIA and Pharma
Julie Holtzople
Independent Consultant, Holtzople Consulting, United States
Value of CTT Disclosure Channels and Thoughts about What Purposeful Transparency Look Like